Treatment outcomes for percutaneous nephrolithotomy in renal allografts.
OBJECTIVE
We reviewed our experience with percutaneous nephrolithotomy (PCNL) in patients with renal allografts over 19 years.


METHODS
We cross-referenced all renal allograft recipients at our institution with all PCNLs performed. We identified 16 renal allograft recipients who underwent a total of 21 PCNL procedures between 1986 and 2005. These charts were abstracted and the outcomes reviewed.


RESULTS
The mean follow-up was 7.2 years. No loss of renal function occurred in the perioperative period. Five patients lost graft function during the follow-up period; however, none of these patients' loss of function was related to the PCNL. No patient had sepsis. Thirteen of the 16 patients were rendered stone free during long-term follow-up.


CONCLUSIONS
PCNL is a safe and effective method of treating nephrolithiasis in a transplanted kidney.
Wyatt
Joseph
J
Division of Urology, Department of Surgery, University of Alabama, Birmingham, Alabama, USA.
Kolettis
Peter N
PN
Burns
John R
JR
D000293:Adolescent; D000328:Adult; D002648:Child; D005260:Female; D006801:Humans; D007669:Kidney Calculi / Q000737:chemistry / Q000209:etiology / Q000628:therapy*; D016030:Kidney Transplantation; D008297:Male; D008875:Middle Aged; D009403:Nephrostomy, Percutaneous / Q000379:methods*; D012189:Retrospective Studies; D014184:Transplantation, Homologous; D016896:Treatment Outcome